Abdominal aortic calcification score can predict all-cause and cardiovascular mortality in maintenance hemodialysis patients

References

• Coresh J, Longenecker JC, Miller ER, et al. Epidemiology of cardiovascular risk factors in chronic renal disease. J Am Soc Nephrol. 1999;9(12 Suppl):S24–S30.
   Google Scholar
• Chertow GM, Raggi P, Chasan-Taber S, et al. Determinants of progressive vascular calcification in haemodialysis patients. Nephrol Dial Transplant. 2004;19(6):1489–1496.
   PubMed Web of Science ®Google Scholar
• Xiong JQ, Chen XM, Liang CT, et al. Prognosis and risk factors for cardiac valve calcification in chinese end-stage kidney disease patients on combination therapy with hemodialysis and hemodiafiltration. Ren Fail. 2022;44(1):224–232.
   PubMed Web of Science ®Google Scholar
• He L, Yang W, Yang P, et al. Higher serum trimethylamine-N-oxide levels are associated with increased abdominal aortic calcification in hemodialysis patients. Ren Fail. 2022;44(1):2019–2027.
   PubMed Web of Science ®Google Scholar
• Wilson PWF, Kauppila LI, O"Donnell CJ, et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation. 2001;103(11):1529–1534.
   PubMed Web of Science ®Google Scholar
• Okuno S, Ishimura E, Kitatani K, et al. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2007;49(3):417–425.
   PubMed Web of Science ®Google Scholar
• Ohya M, Otani H, Kimura K, et al. Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients. Clin Exp Nephrol. 2011;15(6):877–883.
   PubMed Web of Science ®Google Scholar
• Hong D, Wu S, Pu L, et al. Abdominal aortic calcification is not superior over other vascular calcification in predicting mortality in hemodialysis patients: a retrospective observational study. BMC Nephrol. 2013;14:120.
   PubMed Web of Science ®Google Scholar
• Verbeke F, Van Biesen W, Honkanen E, CORD Study Investigators, et al. Prognostic value of aortic stiffness and calcification for cardiovascular events and mortality in dialysis patients: outcome of the calcification outcome in renal disease (CORD) study. Clin J Am Soc Nephrol. 2011;6(1):153–159.
   PubMed Web of Science ®Google Scholar
• Kauppila LI, Polak JF, Cupples LA, et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis. 1997;132(2):245–250.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–458.
   PubMed Web of Science ®Google Scholar
• Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the european society of hypertension (ESH) and of the european society of cardiology (ESC). European Heart Journal. 2013;34(28):2159–2219.
   PubMed Web of Science ®Google Scholar
• Rakowski H, Appleton C, Chan KL, et al. Canadian consensus recommendations for the measurement and reporting of diastolic dysfunction by echocardiography: from the investigators of consensus on diastolic dysfunction by. J Am Soc Echocardiogr. 1996;9(5):736–760.
   PubMedGoogle Scholar
• Kwon HY, Lee OH, Kim MJ, et al. The association between mortality and abdominal aortic calcification and relation between its progression and serum calcium concentration in chronic hemodialysis patients. Kidney Res Clin Prac. 2014;33(2):95–102.
   PubMedGoogle Scholar
• Kidney Disease: improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney Disease-Mineral and bone disorder (CKD-MBD). Kidney Inter Suppl. 2017;7(1):1–59.
   PubMed Web of Science ®Google Scholar
• London GM, Guerin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18(9):1731–1740.
   PubMed Web of Science ®Google Scholar
• Honkanen E, Kauppila L, Wikström B, CORD study group, et al. Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant. 2008;23(12):4009–4015.
   PubMed Web of Science ®Google Scholar
• Chen HC, Wang WT, Hsi CN, et al. Abdominal aortic calcification score can predict future coronary artery disease in hemodialysis patients: a 5-year prospective cohort study. BMC Nephrol. 2018;19(1):313.
   PubMedGoogle Scholar
• Walsh CR, Cupples LA, Levy D, et al. Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: the framingham heart study. Am Heart J. 2002;144(4):733–739.
   PubMed Web of Science ®Google Scholar
• Witteman J, Grobbee D, Valkenburg HA, et al. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet. 1994;343(8896):504–507.
   PubMed Web of Science ®Google Scholar
• Oliveira R, Okazaki H, Stinghen A, et al. Vascular calcification in chronic kidney disease: a review. J Bras Nefrol. 2013;35(2):147–161.
   PubMedGoogle Scholar
• Chen HC, Chou CY, Lin HJ, et al. Abdominal aortic calcification score predicts the occurrence of coronary artery disease in Middle-aged peritoneal dialysis patients. Nephrology. 2019;24(3):336–340.
   PubMed Web of Science ®Google Scholar
• Wang Z, Jiang A, Wei F, et al. Cardiac valve calcification and risk of cardiovascular or all-cause mortality in dialysis patients: a meta-analysis. BMC Cardiovasc Disord. 2018;18(1):12.
   PubMedGoogle Scholar
• Kraus MA, Kalra PA, Hunter J, et al. The prevalence of vascular calcification in patients with end-stage renal disease on hemodialysis: a cross-sectional observational study. Ther Adv Chronic Dis. 2015;6(3):84–96.
   PubMed Web of Science ®Google Scholar
• Wang L, Cheng H, Zou X, et al. Prevalence and correlates of cardiovascular calcification and its prognostic effects among patients with chronic kidney disease: results from the C-STRIDE study. Front Public Health. 2021;9:762370.
   PubMed Web of Science ®Google Scholar
• Bai J, Zhang X, Zhang A, et al. Cardiac valve calcification is associated with mortality in hemodialysis patients: a retrospective cohort study. BMC Nephrol. 2022;23(1):43.
   PubMed Web of Science ®Google Scholar
• Bajaj NS, Osborne MT, Gupta A, et al. Coronary microvascular dysfunction and cardiovascular risk in obese patients. J Am Coll Cardiol. 2018;72(7):707–717.
   PubMed Web of Science ®Google Scholar
• Turkmen K, Demirtas L, Topal E, et al. Predictive value of atrial electromechanical delay on Long-Term cardiovascular outcomes in hemodialysis patients. Am J Nephrol. 2015;42(3):239–249.
   PubMed Web of Science ®Google Scholar
• Kilpatrick RD, Mcallister CJ, Kovesdy CP, et al. Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol. 2007;18(1):293–303.
   PubMed Web of Science ®Google Scholar
• Moradi H, Streja E, Kashyap ML, et al. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients. Nephrol Dial Transplant. 2014;29(8):1554–1562.
   PubMed Web of Science ®Google Scholar
• Lamina C, Kronenberg F, Stenvinkel P, et al. Association of changes in bone mineral parameters with mortality in haemodialysis patients: insights from the ARO cohort. Nephrol Dial Transplant. 2020;35(3):478–487.
   PubMed Web of Science ®Google Scholar
• Floege J, Kim J, Ireland E, ARO Investigators, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a european haemodialysis population. Nephrol Dial Transplant. 2011;26(6):1948–1955.
   PubMed Web of Science ®Google Scholar
• Fouque D, Roth H, Pelletier S, et al. Control of mineral metabolism and bone disease in haemodialysis patients: which optimal targets? Nephrol Dial Transplant. 2013;28(2):360–367.
   PubMed Web of Science ®Google Scholar
• Spoendlin J, Paik JM, Tsacogianis T, et al. Cardiovascular outcomes of Calcium-Free vs Calcium-Based phosphate binders in patients 65 years or older with end-stage renal disease requiring hemodialysis. JAMA Intern Med. 2019;179(6):741–749.
   PubMed Web of Science ®Google Scholar